Yuki Hasegawa | Bioelectronics and Biomaterials | Research Excellence Award

Published on by TOT Awards

Assoc. Prof. Dr. Yuki Hasegawa | Bioelectronics and Biomaterials | Research Excellence Award

Saitama University | Japan

Assoc. Prof. Dr. Yuki Hasegawa research focuses on advancing sensor technology and measurement systems with strong emphasis on gas sensors, taste sensors, electrochemical sensing, and plant bioelectrical potential measurement for environmental and agricultural applications. Core contributions include the design, fabrication, and evaluation of functional material–based sensors and miniaturized sensing platforms capable of stable, sensitive, and reproducible measurements under real-world conditions. Innovative experimental methodologies and signal analysis techniques have been developed to improve sensor selectivity, long-term stability, and response reliability. Research outcomes support interdisciplinary applications spanning environmental monitoring, smart agriculture, and bio-sensing systems, enabling more accurate detection of chemical and biological signals. The work integrates electrical engineering principles with materials science and measurement engineering, contributing to scalable and practical sensing solutions. Findings have been disseminated through high-impact peer-reviewed international journals and conferences indexed in SCI/SCIE and Scopus, strengthening global knowledge exchange in sensing technologies. Scholarly impact is reflected through citation metrics, with 306 total citations (124 since 2020), an h-index of 9 (6 since 2020), and an i10-index of 9 (2 since 2020), demonstrating consistent research influence and relevance. Overall, the research advances next-generation sensing systems and supports sustainable technological development in environmental and agricultural engineering.

Citation Metrics (Google Scholar)

Total Citations
306

Citations: 306 |
h-index: 9 |
i10-index: 9

🟦 Citations    🟩 h-index    🟥 i10-index


View Google Scholar Profile

Featured Publications

Arriel Makembi Bunkete | Health Professions | Best Researcher Award

Published on by TOT Awards

Dr. Arriel Makembi Bunkete | Health Professions | Best Researcher Award

University of Kinshasa | Congo, Democratic Republic of the

Dr. Arriel Makembi Bunkete is a dedicated nephrologist and internal medicine specialist whose clinical and scientific work focuses on kidney transplantation, dialysis innovations, and the epidemiology of chronic kidney disease across diverse and resource-limited settings. He has developed a strong research identity through his contributions to transplant coordination, acute and chronic dialysis strategies, extracorporeal purification techniques, clinical nephrology, glomerular diseases, and the management of toxicological and environmental kidney injuries. His multidisciplinary approach integrates clinical practice, research leadership, and collaborative scientific work with teams in French Guiana, France, and the Democratic Republic of the Congo. Dr. Bunkete’s research addresses critical challenges such as anemia in kidney transplant recipients, sickle cell nephropathy, lupus nephritis activity, paraquat poisoning, high blood lead levels in dialysis patients, and the implementation of home hemodialysis in remote territories. His scientific output includes peer-reviewed articles, case reports, international conference abstracts, and involvement in ongoing epidemiological studies. Recognized for his growing academic influence, he has accumulated 4 citations, an h-index of 1, and an i10-index of 0 (Google Scholar metrics), with comparable citation performance indexed in Scopus. He also contributes as a reviewer for leading nephrology journals, reflecting his commitment to advancing global renal research. His work has received competitive research grant support for studies on APOL1 variants and chronic kidney disease in French Guiana, reinforcing his standing as an emerging investigator in tropical nephrology and transplant medicine. With a strong scientific footprint, ongoing research leadership, and steady scholarly growth, Dr. Bunkete demonstrates the qualities associated with the Best Researcher Award in nephrology.

Publication Profile

Google Scholar

Featured Publications

Bunkete, A. M. (2025). Home hemodialysis in French Guiana: Transforming logistical challenges into healthcare opportunities. Bulletin de la Dialyse à Domicile, 8(2), 107–111.

Kabasele, D. B., Bunkete, A. M., Mbayabo, G., Lumbala, P., Matondo, O., Aloni, M., et al. (2025). Hydroxyurea and regression of sickle cell nephropathy: Open clinical trial in a pediatric population in DR Congo. Kidney360.

Bunkete, A. M., Kasonga, P. K., Fermigier, F., & Djiconkpode, I. (2025). WCN25-137: Pediatric nephrology in French Guiana – Overview and outlook. Kidney International Reports, 10(2), S615.

Anga, K., Makembi, A., Amisi, É., Delpierre, É., Ha, V. H. T., Mbombo, W., et al. (2024). Morbidity and mortality of acute renal failure in COVID-19 patients in intensive care according to waves/variant: Case of the Grand Hôpital de l’Est Francilien site de Meaux. Open Journal of Internal Medicine, 14(1), 16–29.

Bunkete, A. M., Belgrine, M., Sidibe, M., Bellony, S., Davodun, T., Djiconkpode, I., et al. (2025). Dialyse péritonéale chez un nourrisson avec insuffisance rénale aiguë sévère: Dialyse réalisée en plein vol lors d’une évacuation sanitaire en Guyane – À propos d’un cas. Bulletin de la Dialyse à Domicile, 8(3), 255–261.

Liu Wenyi | Health Sciences | Best Researcher Award

Published on by TOT Awards

Dr. Liu Wenyi | Health Sciences | Best Researcher Award

Cancer Hospital Chinese Academy of Medical Sciences | China

Dr. Liu Wenyi is a thoracic-surgery specialist whose research focuses on advanced treatments for thoracic malignancies especially esophageal and lung cancers emphasising organ-preservation strategies, neoadjuvant chemo-/chemo-immunotherapy, imaging- and machine-learning-based response assessment, and translational biomarkers for surgical decision-making. His work has contributed to the evolving paradigm of less-invasive surgery and more personalised multimodal care. For example, his recent narrative review “Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions” is a state-of-the-field synthesis published in Cancers  highlighting novel surveillance-based approaches in esophageal squamous cell carcinoma. His Google Scholar/Scopus profile indicates approximately 10 publications and a current h-index of 5 (citations ~80) under his name. This volume reflects a mid-career emerging investigator whose trajectory is marked by high-impact topics (thoracic oncology, immunotherapy, AI-enabled imaging) and whose top publications already appear in high-visibility journals. Dr. Liu’s work is characterized by integrating minimally invasive surgical techniques, cutting-edge neoadjuvant systemic treatments and advanced predictive modelling to stratify patients for surgical risk and organ-sparing pathways thus contributing to both improved patient quality of life and optimized oncologic outcomes.His outstanding contributions to clinical innovation and scientific research excellence reflect strong merit for recognition under the Best Researcher Award .

Publication Profile

Orcid

Featured Publications

Liu, W., Guo, X., Zhao, H., Yu, X., Wang, C., Du, L., Wang, F., & Mu, J. (2020). Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: A single-center initial experience. Journal of Thoracic Disease, 12(9), 4908-4914.

Liu, W., Tang, J., Li, X., Gong, L., Yang, D., Yin, H., Wang, W., & Zhang, B. (2025). Reduction in surgical scope after neoadjuvant chemotherapy and immunotherapy for non-small cell lung cancer. Oncology Letters, 30(5), 501.

Liu, W., Sui, Z., Wang, C., Deng, Y., Cai, S., Jia, R., Yu, Z., Kang, M., & Zhang, B. (2025). Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer. Frontiers in Cell and Developmental Biology, 13, 1679782.

Hong, Z., Xie, S., Xu, H., Ke, S., Liu, W., Huang, S., Chen, S., Xie, J., Xu, J., & Kang, M. (2025). Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/chemoimmunotherapy: A multi-center cohort study. European Journal of Surgical Oncology, 51(2), 109500.

Liu, W., Zhang, B., Wang, C., Yu, X., Du, L., Yu, Z., & Kang, M. (2025). Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions. Cancers, 17(21), 3559.

 

Tanjirul Islam | Public Health | Young Researcher Award

Published on by TOT Awards

Réla Bodea | Medicine| Best Researcher Award

Published on by TOT Awards

Navid Abedpoor | Health | Young Researcher Award

Published on by TOT Awards

Dr. Navid Abedpoor | Health | Young Researcher Award

Researcher at Islamic Azad university of Isfahan, Iran.

Dr. Navid Abedpoor Dardashti is a dynamic Ph.D. student in the Department of Physiology at the Faculty of Sport Science, Islamic Azad University, Isfahan (Khorasgan) Branch, Iran. With a strong foundation in sport science, food engineering, and nutrition, Dr. Abedpoor has seamlessly integrated molecular biology and physiology into his research. His work primarily focuses on understanding metabolic diseases, inflammation, and oxidative stress using exercise physiology and nutraceutical interventions. He has authored over 20 peer-reviewed articles and several book chapters in the field of sport nutrition, diabetes, cancer biology, and herbal medicine. Dr. Abedpoor’s collaborative efforts span various esteemed institutions, including Royan Institute and University of Isfahan. A passionate researcher, his work blends experimental science with in-silico bioinformatics, yielding innovative insights into non-coding RNAs, senolytic therapies, and gut-brain axis modulation. In addition to research, he actively contributes as a peer reviewer for prominent journals and remains committed to interdisciplinary innovation.

Professional Profile

Scopus Profile 
ORCID

🎓 Education 

Dr. Abedpoor is currently pursuing his Ph.D. in Physiology at the Faculty of Sport Science, Islamic Azad University, Isfahan (Khorasgan) Branch. His doctoral research centers on the impact of exercise and nutrition on inflammation, oxidative stress, and chronic disease progression. He previously earned a Master’s degree in Sport and Nutrition from the same institution, with a focus on the physiological effects of branched-chain amino acids in trained mice, combining nutritional strategies with exercise science. His academic journey began with a Bachelor of Science in Food Sciences and Engineering from the Department of Agriculture, Islamic Azad University, where he explored food biotechnology and bioactive compounds. This combination of training in nutrition, molecular biology, and sport physiology has shaped his multifaceted approach to research in chronic diseases and therapeutic interventions.

👨‍💼 Experience 

Dr. Abedpoor has held several research-oriented positions at leading Iranian academic institutions. He is currently working as a researcher at the Islamic Azad University of Isfahan, where he investigates molecular pathways involved in chronic disease management using exercise and dietary interventions. Prior to this, he conducted research at the University of Isfahan on mitochondrial dysfunction, inflammation, and diabetes. From 2012 to 2019, he was affiliated with the Royan Institute’s Cellular Biotechnology Lab, where he gained experience in cancer biology, regenerative medicine, and genetic modeling. Across these roles, Dr. Abedpoor has worked with in vivo animal models and employed laboratory techniques such as PCR, ELISA, Western blotting, and gene expression profiling. His expertise also extends to computational biology and systems-based research, allowing him to investigate interactions between genes, proteins, and metabolic pathways.

🔬 Research Interest 

Dr. Abedpoor’s research is focused on bridging exercise physiology, nutrition science, and molecular biology to develop novel interventions for chronic metabolic and inflammatory diseases. His key areas of interest include adipose tissue browning through the Irisin–PGC-1α axis, modulation of inflammation using herbal compounds, and regulation of the brain–gut axis. He is particularly interested in the therapeutic use of natural compounds and nutraceuticals in conditions such as diabetes, obesity, neurodegeneration, and cancer. He also explores the role of non-coding RNAs and lncRNAs as diagnostic biomarkers and therapeutic targets. Through a combination of wet lab experimentation and in silico bioinformatics, Dr. Abedpoor identifies novel molecular targets and evaluates their relevance using gene expression, signaling pathways, and protein–gene interaction analyses. His long-term goal is to translate his findings into clinical therapies that improve metabolic health and reduce disease burden.

🏆 Awards and Recognitions 

Dr. Abedpoor has received recognition for multiple research articles published in high-impact journals such as Molecular Neurobiology, Scientific Reports, Frontiers in Oncology, and Environmental Research. His contribution to academic literature includes authoring book chapters published by Nova Science Publishers on subjects like inflammation, amino acids, and gene regulation. He has served as a peer reviewer for prestigious journals including ACS Chemical Neuroscience, Frontiers in Molecular Biosciences, and Diabetes Therapy. His scientific insights have been presented at national and international conferences related to sport science, physiology, and computational biology. Additionally, he was awarded a research fellowship at Royan Institute, Iran’s premier research center for biotechnology and stem cell therapy, where he participated in several multidisciplinary projects.

Skills

Dr. Abedpoor brings a comprehensive and interdisciplinary skill set to his research work. His laboratory expertise includes molecular biology techniques such as RNA and DNA extraction, PCR, Western blotting, ELISA, and immunohistochemistry. He is proficient in handling in vivo animal models of diabetes, obesity, and physical training interventions. He has advanced knowledge of bioinformatics tools including Cytoscape, STRING, R software, and MetaCore for analyzing genetic and protein interaction networks. He also uses computational pharmacology for drug modeling and systems biology. In addition to lab-based work, Dr. Abedpoor is skilled in scientific writing, literature review, and meta-analysis. He regularly uses SPSS and GraphPad Prism for statistical evaluation and data visualization. His communication skills are reflected in his peer-reviewed publications, book contributions, and reviewer roles for multiple scientific journals. These diverse capabilities enable him to navigate across disciplines and contribute effectively to academic and translational research.

Conclusion

Navid Abedpoor Dardashti is highly suitable for the Research for Young Researcher Award. He exemplifies what the award seeks: early-career brilliance, interdisciplinary innovation, and a strong track record of impactful research. His productivity, scientific curiosity, and service to the academic community position him as a rising star in biomedical and sport science research.

📚Top Noted  Publications 

Mitigating Diabetic Cardiomyopathy: The Synergistic Potential of Sea Buckthorn and Metformin Explored via Bioinformatics and Chemoinformatics
• Authors: Navid Abedpoor, et al.
• Year: 2025
• Journal: Biology

The role of Sparasis Latifolia and Aerobic Exercise on Anti-inflammatory Activities…
• Authors: Navid Abedpoor, et al.
• Year: 2025
• Journal: Journal of Nutrition Sciences and Food Technology
Exploring the dynamics of exercise intensity on male fertility…
• Authors: Navid Abedpoor, et al.
• Year: 2024
• Journal: Frontiers in Reproductive Health
Sparassis latifolia and exercise training… (5-fluorouracil side effects)
• Authors: Navid Abedpoor, et al.
• Year: 2024
• Journal: Cancer Cell International
System biology analysis for gastric cancer (maggot compounds)
• Authors: Navid Abedpoor, et al.
• Year: 2023
• Journal: Environmental Research
Types of Cell Death from a Molecular Perspective
• Authors: Navid Abedpoor, et al.
• Year: 2023
• Journal: Biology
The molecular perspective on melanoma and T-cells
• Authors: Navid Abedpoor, et al.
• Year: 2023
• Journal: Environmental Research
Pathomechanisms of Non-Coding RNAs and Oxidative Stress in Type 2 Diabetes
• Authors: Navid Abedpoor, et al.
• Year: 2023
• Journal: F1000Research
Polyherbal Compounds & Mobility Training in Alzheimer’s
• Authors: Navid Abedpoor, et al.
• Year: 2023
• Journal: Journal of Molecular Neuroscience
 Natural remedies from flaxseed for diabetic heart conditions
• Authors: Navid Abedpoor, et al.
• Year: 2022
• Journal: Journal of Food Biochemistry
 Combination of endurance exercise and SGTC
• Authors: Navid Abedpoor, et al.
• Year: 2022
• Journal: Nutrition & Metabolism

James Kim | Stemcells | Best Researcher Award

Published on by TOT Awards

Dr.James Kim | Stemcells | Best Researcher Award

Bioprocess Scientist at PBS Biotech Inc, United States.

Dr. James Kim is a distinguished bioprocess scientist specializing in chemical and biomolecular engineering. Currently serving at PBS Biotech Inc., he focuses on advancing bioprocessing techniques, downstream analytics, and stem cell research. His expertise extends from his postdoctoral research at the University of Washington, where he pioneered exosome analysis for cancer diagnostics using nano-flow cytometry. During his Ph.D. at Ohio State University, he explored magnetic cell separation for clinical applications and studied hydrodynamic stress in bioreactors. Dr. Kim has collaborated with prestigious institutions, including the NIH, and has made significant contributions to regenerative medicine and biomanufacturing. His research seamlessly integrates fundamental scientific principles with industrial applications, reinforcing his reputation as a leading expert in biomedical engineering.

professional profiles📖

ORCID

Education 🎓

Dr. Kim earned his Ph.D. in Chemical and Biomolecular Engineering from Ohio State University (2015–2020) under the mentorship of Dr. Jeffrey Chalmers. His doctoral research focused on developing magnetic separation techniques for clinical applications and analyzing the impact of hydrodynamic stress on cell cultures in bioreactors. Before his doctoral studies, he completed a Bachelor of Science in Engineering (B.S.E.) in Chemical Engineering from the University of Michigan (2009–2015), graduating with cum laude honors. His undergraduate studies emphasized fluidics, flow cytometry, and bioprocess engineering, providing a solid foundation for his later research in cell separation, microfluidics, and assay development. Throughout his academic career, Dr. Kim demonstrated an interdisciplinary approach, integrating principles from engineering and biomedical sciences to drive innovation in biotechnology.

work Experience💼

With a diverse background in bioprocessing and analytical development, Dr. Kim currently works as a Bioprocess Scientist at PBS Biotech Inc., where he leads efforts in process scale-up, analytics development, and product testing for stem cell biomanufacturing. Prior to this, he conducted postdoctoral research at the University of Washington (2020–2023), where he played a pivotal role in advancing nano-flow cytometry for exosome-based cancer diagnostics while collaborating with leading industry partners like Beckman Coulter and the NIH. His Ph.D. research at Ohio State University (2015–2020) involved pioneering work in magnetic separation for anemia and cancer diagnostics, as well as characterizing hydrodynamic stress in bioreactors. His extensive experience bridges fundamental research with industrial applications, making significant contributions to the fields of regenerative medicine, precision diagnostics, and biomanufacturing.

Research Focus

Dr. Kim’s research centers on advancing bioprocessing strategies, optimizing bioreactor performance, and developing innovative cell separation techniques. His work in bioprocessing and bioreactor optimization includes modeling oxygen transfer for stem cell culture to improve scalability in regenerative medicine. He has significantly contributed to flow cytometry and exosome characterization, focusing on the standardization of single-molecule flow cytometry techniques for early-stage cancer diagnostics. Additionally, his expertise in magnetic cell separation has led to novel applications in anemia, sickle cell disease, and cancer diagnostics. His interdisciplinary research aims to bridge the gap between laboratory discoveries and scalable biomanufacturing, facilitating advancements in cell therapy, regenerative medicine, and precision diagnostics.

Awards & Honors🏆 

Dr. Kim has received numerous accolades throughout his career, including a Poster Presentation Scholarship at the prestigious ECI: Cell Culture Engineering XVIII Conference in 2023, which awarded him $2,000 for his research contributions. In 2016, he earned another Poster Presentation Scholarship ($500) at the International Advanced Course on Regenerative Medicine Manufacturing. He has actively presented his work at multiple AIChE Annual Meetings between 2017 and 2019, receiving recognition for his oral and poster presentations. His collaborative research efforts with the NIH and industry leaders in the field of exosome flow cytometry have also been acknowledged, further solidifying his standing as an expert in bioprocess engineering and regenerative medicine..

Conclusion✅

Dr. James Kim is a strong candidate for the Best Researcher Award, given his significant contributions to bioprocess engineering and biomedical diagnostics. His work bridges fundamental science and industrial applications, demonstrating innovation in process and instrumentation development. While he excels in research output and industry collaboration, additional focus on patenting, professional memberships, and increasing citation impact could further strengthen his profile. Overall, he is a well-qualified contender for this award.

Publications to Noted 📚

Measurement of Oxygen Transfer Rate and Specific Oxygen Uptake Rate of h-iPSC Aggregates in Vertical Wheel Bioreactors to Predict Maximum Cell Density Before Oxygen Limitation (2025)
Authors: James Kim, Omokhowa Agbojo, Sunghoon Jung, Matt Croughan
Citations: Not available

Comparison of EV Characterization by Commercial High‐Sensitivity Flow Cytometers and a Custom Single‐Molecule Flow Cytometer (2024)
Authors: James Kim, Shihan Xu, Seung‐Ryoung Jung, Alya Nguyen, Yuanhua Cheng, Mengxia Zhao, Bryant S. Fujimoto, Wyatt Nelson, Perry Schiro, Jeffrey L. Franklin, et al.
Citations: Not available

Intrinsically Magnetic Susceptibility in Human Blood and Its Potential Impact on Cell Separation: Non-Classical and Intermediate Monocytes Have the Strongest Magnetic Behavior in Fresh Human Blood (2021)
Authors: J. Gómez-Pastora, J. Kim, V. Multanen, M. Weigand, N.A. Walters, E. Reátegui, A.F. Palmer, M.H. Yazer, M. Zborowski, J.J. Chalmers
Citations: Not available

Magnetophoretic and Spectral Characterization of Oxyhemoglobin and Deoxyhemoglobin: Chemical Versus Enzymatic Processes (2021)
Authors: M.R.H. Weigand, J. Gómez-Pastora, J. Kim, M.T. Kurek, R.J. Hickey, D.C. Irwin, P.W. Buehler, M. Zborowski, A.F. Palmer, J.J. Chalmers
Citations: Not available

Hyperferritinemia in Critically Ill COVID-19 Patients – Is Ferritin the Product of Inflammation or a Pathogenic Mediator? (2020)
Authors: J. Gómez-Pastora, M. Weigand, J. Kim, X. Wu, J. Strayer, A.F. Palmer, M. Zborowski, M. Yazer, J.J. Chalmers
Citations: Not available

Quantification of the Mean and Distribution of Hemoglobin Content in Normal Human Blood Using Cell Tracking Velocimetry (2020)
Authors: James Kim, Jenifer Gómez-Pastora, Christopher J. Gilbert, Mitchell Weigand, Nicole A. Walters, Eduardo Reátegui, Andre F. Palmer, Mark Yazer, Maciej Zborowski, Jeffrey J. Chalmers
Citations: Not available

Single Cell Analysis of Aged RBCs: Quantitative Analysis of the Aged Cells and Byproducts (2019)
Authors: J. Kim, M. Weigand, A.F. Palmer, M. Zborowski, M.H. Yazer, J.J. Chalmers
Citations: Not available

Quantitative Characterization of the Regulation of Iron Metabolism in Glioblastoma Stem‐Like Cells Using Magnetophoresis (2019)
Authors: Kyoung‐Joo J. Park, James Kim, Thomas Testoff, Joseph Adams, Miranda Poklar, Maciej Zborowski, Monica Venere, Jeffrey J. Chalmers
Citations: Not available

A Subpopulation of Monocytes in Normal Human Blood Has Significant Magnetic Susceptibility: Quantification and Potential Implications (2019)
Authors: James Kim, Jenifer Gómez‐Pastora, Mitchell Weigand, Marnie Potgieter, Nicole A. Walters, Eduardo Reátegui, Andre F. Palmer, Mark Yazer, Maciej Zborowski, Jeffrey J. Chalmers
Citations: Not available

Correlation of Simulation/Finite Element Analysis to the Separation of Intrinsically Magnetic Spores and Red Blood Cells Using a Microfluidic Magnetic Deposition System (2018)
Authors: J. Sun, L. Moore, W. Xue, J. Kim, M. Zborowski, J.J. Chalmers
Citations: Not available

 

 

Heng Zhang | Biomedical Research | Best Researcher Award

Published on by TOT Awards

Dr. Heng Zhang | Biomedical Research | Best Researcher Award

Research Scientist at Versiti Blood Research Institute, United States

Dr. Heng Zhang is a Research Scientist specializing in integrin structure and signaling at the Blood Research Institute, Versiti, U.S. His expertise spans biochemical and structural biology, molecular genetics, and biotechnology. With a strong academic background from Waikato University and Shandong Normal University, he has contributed significantly to the fields of virology, protein interactions, and blood-related research. His work includes pioneering studies on integrins, viral receptors, and hemophilia mutations. Dr. Zhang has received numerous prestigious awards and serves as a reviewer for scientific journals. His research has led to patents and publications in high-impact journals, demonstrating his commitment to advancing biomedical science.

professional profiles📖

Scopus Profile

ORCID

Education 🎓

Dr. Zhang earned his Ph.D. in Biochemical and Structural Biology from Waikato University, New Zealand, in 2019, where he focused on protein structure and function, particularly in relation to bovine salivary proteins and microbial interactions. Before that, he obtained an M.Sc. in Molecular Genetics with First-Class Honors from Waikato University, specializing in genetic and biochemical approaches to understanding molecular pathways. His academic journey began at Shandong Normal University, China, where he completed a B.Sc. in Biotechnology in 2009, gaining foundational knowledge in biotechnology, molecular biology, and genetic engineering.

work Experience💼

Currently, Dr. Zhang serves as a Research Scientist at the Blood Research Institute, Versiti, where he investigates integrin structure and signaling. Previously, he worked as a Postdoctoral Fellow at the same institute from 2019 to 2023, focusing on molecular mechanisms in virology and blood coagulation. His experience also includes teaching molecular biology and biochemistry as a Teaching Assistant at Waikato University from 2013 to 2019, where he mentored students and supported laboratory research. Additionally, he worked as a Research Technologist at Waikato University from 2013 to 2014, conducting laboratory experiments related to protein structure and microbial interactions.

🏆 Awards and Honors

Dr. Zhang has received multiple accolades throughout his career. In 2024, he was honored with the Education Committee Award from Versiti Blood Research Institute. During his graduate studies, he earned the DairyNZ Graduate Student Award from AgResearch Ltd (2015-2019) and multiple internal awards from Waikato University in 2014 and 2012. His academic excellence was recognized early on with First and Second Class Scholarships from Shandong Normal University (2005-2009) and a Second Prize award in the China High School Biology Olympiad in 2003.

Skills

Dr. Zhang is highly skilled in structural biology, with expertise in X-ray crystallography, cryo-EM, and protein modeling. He has strong computational biology skills, using tools such as AlphaFold and molecular dynamics simulations. His biochemical expertise includes protein purification, enzyme kinetics, and cellular assays, while his genetic engineering experience covers CRISPR, recombinant protein expression, and cloning. As an active contributor to the scientific community, he serves as a reviewer for Frontiers in Cardiovascular Medicine and has been involved in patent development for antiviral receptor-based technologies.

Research Focus

Dr. Zhang’s research revolves around integrin structure and signaling, exploring mechanisms of cell adhesion and immune response regulation. He has made significant contributions to understanding hemophilia and blood disorders, utilizing computational modeling to study coagulation factors. His work in virology includes investigating cell-attachable viral receptors for infectious disease control. Additionally, he applies structural biology techniques, including cryo-EM and AlphaFold-based predictions, to study protein interactions. His research extends to biomedical engineering and drug development, with a focus on innovative therapeutic approaches for blood-related diseases.

Conclusion✅

Dr. Heng Zhang is an excellent candidate for the Best Researcher Award due to his substantial contributions to biomedical and structural biology research. His impressive publication record, patents, mentorship roles, and international collaborations make him a strong contender. However, further advancements in leading research projects, securing independent funding, and expanding his first-author publications in top journals could further bolster his qualifications for the award. Overall, he demonstrates outstanding research excellence with strong potential for future leadership in his field.

📚Publications to Noted

 

Predicting the effects of single pathological mutations in Hemophilia A and Type 2N Von Willebrand Diseases using AlphaFold2‐multimer and AlphaFold3

Authors: Not provided

Citations: Not provided

Year: 2025

Facilitating and restraining virus infection using cell‐attachable soluble viral receptors

Authors: Not provided

Citations: Not provided

Year: 2024

Integrin α 5 β 1 contributes to cell fusion and inflammation mediated by SARS‐CoV‐2 spike via RGD‐independent interaction

Authors: Not provided

Citations: Not provided

Year: 2023

Family‐wide analysis of integrin structures predicted by AlphaFold2.

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2023

Intracellular tPA–PAI-1 interaction determines VLDL assembly in hepatocytes

Authors: Not provided

Citations: Not provided

Year: 2023

Coagulopathy in COVID‐19 and anticoagulation clinical trials

Authors: Not provided

Citations: Not provided

Year: 2022

The three dimensional structure of Bovine Salivary Protein 30b (BSP30b) and its interaction with specific rumen bacteria.

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2019

A new method to extract and purify DNA from allophanic soils and paleosols, and potential for paleoenvironmental reconstruction and other applications

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2016

What can the geographic distribution of mtDNA haplotypes tell us about the invasion of New Zealand by house mice Mus musculus?

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2016

DNA adsorption by nanocrystalline allophane spherules and nanoaggregates, and implications for carbon sequestration in Andisols

Authors: Heng Zhang (assumed)

Citations: Not provided

Year: 2016

 

MattiaLoppini | Orthopaedics | Best Researcher Award

Published on by TOT Awards

Assoc. Prof. Dr Mattia Loppini | Orthopaedics | Best Researcher Award

Associate Professor  at Humanitas University/IRCCS Humanitas Research Hospital, Italy

Dr. Mattia Loppini is an accomplished Associate Professor at Humanitas University and IRCCS Humanitas Research Hospital in Milan, Italy. A medical doctor with a PhD in Oncology Orthopaedics, he specializes in hip and knee surgeries, particularly joint replacement procedures. With a strong academic and clinical foundation, Dr. Loppini has dedicated his career to advancing orthopaedic care through teaching, research, and patient care. He has served in progressive academic roles, from Assistant Professor to his current position, and is actively involved in mentoring PhD candidates in applied clinical research. His teaching contributions span undergraduate, graduate, and professional programs, making him a key figure in medical education. Dr. Loppini’s commitment to innovation and excellence in orthopaedics is matched by his dedication to shaping the future of the field through research and mentorship.

Professional profiles📖

ORCID

Scopus Profile

Google Scholar

Education 🎓

Dr. Mattia Loppini’s educational journey exemplifies excellence and dedication to orthopaedics and trauma surgery. He earned his Medical Degree from the University Campus Bio-Medico of Rome in 2009, followed by completing his residency in Orthopaedic and Trauma Surgery in 2015. From 2012 to 2015, he pursued a Doctor of Philosophy (PhD) in Oncology Orthopaedics at the same institution. Dr. Loppini further advanced his expertise by completing an Advanced Training Course in Clinical Epidemiology at Humanitas University in 2017. He began his academic career as an Assistant Professor in 2017, advancing to Associate Professor in 2024. He also obtained the prestigious Scientific National Abilitation for Full Professorship in Locomotor Apparatus Diseases and Rehabilitative Medicine in 2022. Dr. Loppini’s academic qualifications underscore his commitment to advancing knowledge and expertise in orthopaedic medicine.

Work Experience💼

Dr. Mattia Loppini boasts a distinguished career in orthopaedics, combining clinical expertise with academic excellence. Currently, he serves as an Associate Professor in the Department of Orthopaedics and Trauma Surgery at Humanitas University, where he specializes in hip diseases and joint replacement surgery. Since 2017, Dr. Loppini has held various teaching and research positions, including Professor of Orthopaedics and Trauma Surgery and Clinical PhD Supervisor. His role as a tutor in orthopaedics and human anatomy has shaped countless medical professionals. Dr. Loppini has also contributed to the Master’s Degree Program in Nursing and Midwifery Science and the MEDTEC Degree Course. Beyond academia, his clinical practice focuses on advanced hip and knee surgical procedures. A personal tutor since 2008, his career reflects his dedication to mentoring and fostering medical talent.

Awards and Honors

Dr. Mattia Loppini’s dedication to education and clinical excellence has earned him several accolades. Among his notable recognitions is his inclusion in the “Top Teachers” platform, acknowledging his outstanding teaching contributions at Humanitas University. He has also achieved the Scientific National Abilitation for Full Professorship in Locomotor Apparatus Diseases and Rehabilitative Medicine, highlighting his academic and research prowess. Dr. Loppini’s consistent performance as a teacher and mentor has cemented his reputation as a leader in medical education. His work in orthopaedics, particularly in hip and knee surgeries, has garnered respect among peers and students alike. While his awards primarily emphasize teaching, his influence on clinical practices and research is evident, showcasing his holistic impact on the field of orthopaedics.

Research Focus

Dr. Mattia Loppini’s research focuses on advancing surgical techniques and clinical outcomes in hip and knee diseases, with a special interest in joint replacement surgery. His work integrates clinical epidemiology to improve patient care and outcomes in orthopaedic surgeries. During his PhD in Oncology Orthopaedics, Dr. Loppini explored cutting-edge methodologies to address complex orthopaedic conditions. His research contributions extend to applied clinical research, where he supervises PhD candidates in developing innovative solutions for musculoskeletal disorders. He also investigates the role of physical and rehabilitative medicine in improving postoperative recovery. By bridging clinical practice with academic inquiry, Dr. Loppini aims to optimize surgical protocols and rehabilitation strategies. His multidisciplinary approach ensures that his research remains relevant, impactful, and patient-centered.

Conclusion✅

Dr. Mattia Loppini is a highly suitable candidate for the Best Researcher Award, given his strong academic foundation, extensive teaching experience, and significant contributions to clinical and academic orthopaedics. While he has achieved remarkable success, addressing areas such as enhancing research output and global collaborations could further solidify his standing as a leader in his field. His commitment to education, research, and clinical excellence makes him an ideal nominee for this prestigious recognition.

📚Publications to Noted

Identification of preoperative predictive markers of periprosthetic joint infection in presumed aseptic revisions of total hip arthroplasty: a retrospective observational study

Authors: Loppini, M., Bella, L.L., Rocchi, C., Rusconi, R., Grappiolo, G.

Citations: 0

Year: 2025

The international Hip Outcome Tool 12 questionnaire (iHOT-12): an Italian language cross-cultural adaptation and validation

Authors: Randelli, F., Fioruzzi, A., Clemente, A., Di Martino, A., Rivera, F.

Citations: 0

Year: 2024

Leveraging transfer learning for predicting total knee arthroplasty failure from post-operative radiographs

Authors: Corti, A., Galante, S., Rauch, R., Corino, V., Loppini, M.

Citations: 0

Year: 2024

Mid-Term Clinical and Radiographic Results of Complex Hip Revision Arthroplasty Based on 3D Life-Sized Model: A Prospective Case Series

Authors: La Camera, F., Di Matteo, V., Pisano, A., Grappiolo, G., Loppini, M.

Citations: 0

Year: 2024

Machine Learning Prediction Model to Predict Length of Stay of Patients Undergoing Hip or Knee Arthroplasties: Results from a High-Volume Single-Center Multivariate Analysis

Authors: Di Matteo, V., Tommasini, T., Morandini, P., Grappiolo, G., Loppini, M.

Citations: 0

Year: 2024

A new classification to characterize and predict treatment of acetabular bone defects

Authors: Loppini, M., Guazzoni, E., Gambaro, F.M., Morenghi, E., Grappiolo, G.

Citations: 0

Year: 2024

Interleukin-1β Polymorphisms Are Genetic Markers of Susceptibility to Periprosthetic Joint Infection in Total Hip and Knee Arthroplasty

Authors: Granata, V., Strina, D., Possetti, V., Sobacchi, C., Inforzato, A.

Citations: 1

Year: 2024

Clinical and Radiographic Outcomes of Hip Revision Surgery and Cerclage Wires Fixation for Vancouver B2 and B3 Fractures: A Retrospective Cohort Study

Authors: Di Matteo, V., La Camera, F., Carfì, C., Grappiolo, G., Loppini, M.

Citations: 0

Year: 2024

Results of Utilizing Cerclage Wires in the Management of Intraoperative Vancouver B1 Fractures in Primary Total Hip Arthroplasties: A Retrospective Cohort Investigation into Clinical and Radiographic Outcomes

Authors: Rocchi, C., Di Matteo, V., Chiappetta, K., Grappiolo, G., Loppini, M.

Citations: 0

Year: 2024

AI-based hip prosthesis failure prediction through evolutional radiological indices

Authors: Bulloni, M., Gambaro, F.M., Chiappetta, K., Corino, V., Loppini, M.

Citations: 0

Year: 2024